VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,186 | -7.2% | 18,793 | +41.6% | 0.02% | -34.6% |
| Q2 2023 | $87,469 | +171.1% | 13,273 | +179.4% | 0.03% | +160.0% |
| Q1 2023 | $32,259 | -85.5% | 4,751 | -84.2% | 0.01% | -86.5% |
| Q4 2022 | $222,594 | +10.2% | 30,121 | +47.4% | 0.07% | -26.0% |
| Q3 2022 | $202,000 | +242.4% | 20,433 | +277.4% | 0.10% | +170.3% |
| Q2 2022 | $59,000 | -58.5% | 5,414 | -57.1% | 0.04% | -47.9% |
| Q1 2022 | $142,000 | -52.2% | 12,631 | -33.3% | 0.07% | -48.6% |
| Q4 2021 | $297,000 | +81.1% | 18,949 | +98.0% | 0.14% | +31.4% |
| Q3 2021 | $164,000 | -25.1% | 9,570 | -6.0% | 0.10% | -23.9% |
| Q2 2021 | $219,000 | – | 10,182 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |